scientifyRESEARCH
research funding database

RESEARCH FUNDING

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 – Clinical Trial Optional)

Share this post

ERC webinar 2024
ERC webinar 2024

The Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 – Clinical Trial Optional) funding call from the National Institutes of Health (NIH) supports exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, and/or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs.

An application may be submitted by a foreign institution in an eligible LMIC or by a domestic (U.S.) institution that demonstrates collaboration with an LMIC institution in an eligible LMIC(s).

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

The R21 phase may not exceed $125,000 in direct costs in any single year of the R21 phase. The R33 phase may not exceed $200,000 in direct costs in any single year of the R33 phase (including indirect costs). Maximum duration of each project is 5 years.

Opportunity ID: PAR-23-318.

Letters of intent are due February 21, 2025 and full applications are due March 21, 2025.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
scientifyRESEARCH
monthly funding newsletter

unsubscribe at any time